CDISC SEND Updates Nonclinical Drug Developers Need to Know
In this blog, Peggy Zorn explores updates to the Standard for Exchange of Nonclinical Data…
Certara2026年4月6日
Seeing is Understanding: Best Practices for Visualizing Nonclinical Study Data
SEND data visualization: best practices for visualizing nonclinical study data to reveal trends, spot outliers,…
Certara2026年2月2日
SEND V4.0 – What to Expect and When to Expect It
2025年4月24日 As the Standard for Exchange of Nonclinical Data (SEND) continues to evolve…
Certara2025年4月24日
Visualizing SEND Data: Why and How
Senior Director, Product Management Peggy is the Customer Success lead for SEND Explorer. She has…
Certara2025年4月21日
Best Practices for Visualization of Nonclinical Study Data in SEND Format (and Beyond)
Thank you for registering for our webinar, Best Practices for Visualization of Nonclinical Study Data…
Certara2025年4月15日
Gain Nonclinical Drug Safety Insights with Real-Time Data Analysis
2025年2月24日 Efficient drug development relies on informed decision-making. For toxicologists, having timely access…
Certara2025年2月24日
The Benefits of Real-Time Nonclinical Safety Data Analysis
Learn how SEND Explorer software helps nonclinical drug developers streamline performing real-time toxicology assessments of…
Certara2025年1月27日
Transforming Non-clinical Drug Development with SEND Explorer
Since 1999, Genmab has been developing therapeutic antibodies and antibody-drug conjugates (ADCs) for treating cancer.…
Certara2024年7月8日
